L2M Launch / Qc Fall 2025 / Spheralis Biolabs

We are developing a new class of antibiotics to treat udder infections in dairy cows caused by Staphylococcus aureus, a particularly difficult and costly problem for farmers. While udder infections in general cost the Canadian dairy industry over $800?million each year, those caused by S. aureus are especially challenging to treat, often leading to milk losses, animal culling, and long-term herd impacts. Our solution is a targeted, animal-compatible antibiotic designed to reach the bacteria inside udder cells—something current treatments struggle to do. Through the L2M Launch program, we aim to refine our market entry strategy, outline our product development plan, and explore funding and partnership models. The program will benefit by helping transform a high-potential university innovation into a real-world solution that improves animal health, reduces on-farm losses, and builds entrepreneurial skills for the next generation of research-driven leaders.

Faculty Supervisor:

François Malouin

Student:

Partner:

V1 Studio

Discipline:

Life Sciences

Sector:

Agriculture and Food; Pharmaceuticals; Health and Related Sciences & Technology

University:

Université de Sherbrooke

Program: